Spironolactone And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 66993-188

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 66993-188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spironolactone 01)

FDA Label Image

Chemical Structure (Spironolactone 02)

FDA Label Image

Principal Display Panel (25 mg/25 mg Tablet Bottle Label)

Principal Display Panel (25 mg/25 mg Tablet Bottle Label)
This is a medication called Spironolactone and Hydrochlorothiazide, which is dispensed in a child-resistant container and must be stored below 77°F (25°C) and protected from light. Each tablet contains 25 mg of Spironolactone and 25 mg of hydrochlorothiazide. The prescribing information should be consulted for dosage and use. It is distributed by Prasco Laboratories and comes in a box containing 100 tablets. The remaining characters are not legible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.